MDVL - Earnings announcements

PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023. "During the second quarter, we were able to sustain the positive momentum that we have experienced since we began focusing on the immense market opportunity for our pharmacy technology in January of this year," said Mark Doerr, Chief Executive Officer of MedAvail. "Of note, we placed an additional two revenue generating MedCenters in the field, bringing our year-to-date total to six, and we reiterate our expectation that we will place 25 net new revenue generating MedCenters in

PHOENIX, May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today reported financial results for the first quarter ended March 31, 2023. "During the first quarter, we made good progress toward our mission of becoming a leader in the development and manufacture of pharmacy technology solutions in the short time since we announced the sale of certain of our SpotRx assets to CVS in January," said Mark Doerr, Chief Executive Officer of MedAvail. "Our pipeline continues to grow, representing a mix of both new and existing partners, and we remain on track to achieve our previously stated goal of adding 25 net new dispe

PHOENIX, May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today announced that the Company will announce financial results for the first quarter ended March 31, 2023, on Thursday, May 18th, after the close of the financial markets. MedAvail management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Call and webcast details:Thursday, May 18th, 2023 @ 4:30pm ETInvestor dial-in: 1- 877-704-4453 (domestic) or 1-201-389-0920 (international)Conference ID: 13738987To access the Call me™ feature, which avoids having to wait for an operator, click here. The live a

PHOENIX, May 15, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative technology-enabled pharmacy company, today announced that the Company will announce financial results for the first quarter ended March 31, 2023, on Monday, May 15th, after the close of the financial markets. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Call and webcast details:Monday, May 15th, 2023 @ 4:30 pm ETInvestor dial-in: 1-888--886-7786 (domestic) or 1-416-764-8641 (international) To access the Call me™ feature, which provides instant phone access to the event, click here. The live aud

PHOENIX, April 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022. "Since assuming the role of CEO in January 2022, I have been impressed by the many growth opportunities addressable by both our pharmacy services and pharmacy technology solutions," said Mark Doerr, Chief Executive Officer of MedAvail. "However, I believe it is in the best interest of our company to balance topline growth with an alternative path that targets accelerated profitability. As such, we made the difficult decision earlier this year to restructure and

PHOENIX, April 12, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today announced that the Company will announce financial results for the fourth quarter and full-year ended December 31, 2022, on Thursday, April 13th, after the close of the financial markets.  MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Call and webcast details:Thursday, April 13th, 2023 @ 4:30pm ETInvestor dial-in: 1-877-704-4453 (domestic) or 1-201-389-0920 (international)Conference ID: 13737951To access the Call me™ feature, which avoids having to wait for an

PHOENIX, March 16, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today announced that the Company will announce financial results for the fourth quarter and full-year ended December 31, 2022 on Thursday, March 30, after the close of the financial markets. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Call and webcast details:Thursday, March 30, 2023 @ 4:30pm ETInvestor dial-in: 1-877-704-4453 (domestic) or 1-201-389-0920 (international)Conference ID: 13736400To access the Call me™ feature, which avoids having to wait for an operat

PHOENIX, Nov. 10, 2022 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today reported financial results for the three months ended September 30, 2022. "During the third quarter, we made significant progress on our key milestones – we achieved and exceeded our target of 100 dispensing MedCenters, delivered gross margin expansion for the second consecutive quarter, and reached savings of 26% on our cash burn rate over the fourth quarter of 2021. We are also pleased with our third quarter performance; despite some headwinds, we continued to meaningfully broaden our retail pharmacy footprint and continued to expand our technology

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced it will report financial results for the third quarter of 2022 on Thursday, November 10, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The conference call can be accessed by registering online for the live audio webcast on the "Investor Relations" section of MedAvail's website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event. About MedAvail MedAvail Holdings, Inc. (NASDAQ:MDVL) is a technology-enabled pharmacy organi

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today reported financial results for the three months ended June 30, 2022. "We continued to execute on our strategic initiatives in the second quarter and are pleased to be introducing our full year revenue guidance. Our strong financial results are a testament to our focus on expanding our retail pharmacy and technology footprint, increasing utilization, and reducing costs across the enterprise," said Mark Doerr, Chief Executive Officer of MedAvail. "We are delighted by the interest in our differentiated retail pharmacy and pharmacy technology solutions and are addressing this demand through our broa

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced it will report financial results for the second quarter of 2022 on Thursday, August 11, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the "Investor Relations" section of MedAvail's website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event. About MedAvail MedAvail Holdings, Inc. (NASDAQ:MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharma

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today reported financial results for the three months ended March 31, 2022. "I am proud of our team's strong start to the year. We delivered robust sales growth in the first quarter and achieved a milestone in our Pharmacy Technology business with the completion of our integration with Epic," said Mark Doerr, Chief Executive Officer of MedAvail. "There is clear momentum and demand for our differentiated pharmacy technology solutions, and we are deliberately investing in our teams and business to drive this growth. We are excited for our path forward and the significant opportunity ahead, as we focus o

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced it will report financial results for the first quarter of 2022 on Thursday, May 12, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the "Investor Relations" section of MedAvail's website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event. About MedAvail MedAvail Holdings, Inc. (NASDAQ:MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy s

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today reported financial results for the three months and full year ended December 31, 2021. "I am excited to have joined MedAvail at a pivotal time when I believe that there is a tremendous need and a rising demand in pharmacy services for our technology and pharmacy solutions. Since joining MedAvail, my confidence in our business has only strengthened further," said Mark Doerr, Chief Executive Officer of MedAvail. "As we look ahead to 2022, I believe that we are strongly positioned with expansion in dispensing deployments and partnerships well underway and a clear roadmap seeking to deliver profitab

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced it will report financial results for the full year and fourth quarter of 2021 on Thursday, March 24, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the "Investor Relations" section of MedAvail's website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event. About MedAvail MedAvail Holdings, Inc. (NASDAQ:MDVL) is a technology-enabled pharmacy organization, providing turnkey in-

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today reported financial results for the three months ended September 30, 2021. "We are encouraged by our third quarter results, highlighted by our recent partnerships to broaden our footprint in Florida. Our expansion opportunities demonstrate the value proposition of our SpotRx embedded pharmacy model. With each new SpotRx deployment and partnership in our targeted states, we are building a foundation to deliver sustainable and scalable growth," said Ed Kilroy, Chief Executive Officer of MedAvail. "As we look to the remainder of 2021, we remain focused on continued execution across our initiatives a

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced it will report financial results for the third quarter 2021 on Monday, November 8, 2021, after market close. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the "Investor Relations" section of the Company's website at: https://investors.medavail.com/. The webcast will be archived and available for replay after the event. About MedAvail MedAvail Holdings, Inc. (NASDAQ:MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today reported financial results for the three months ended June 30, 2021. "We are pleased with our second quarter results which reflect continued momentum, as our sales grew 118% on a sequential basis," said Ed Kilroy, Chief Executive Officer of MedAvail. "We are looking forward to bringing our Retail Pharmacy Services to the Florida region in the second half of 2021, and we remain excited about the opportunity to continue adding value to our current partners, as evidenced by our recent expansions in several key accounts. We are also pleased to announce two significant strategic endeavors: a new Reta

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced it will report financial results for the second quarter 2021 on Wednesday, August 11, 2021 after market close. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the "Investor Relations" section of the Company's website at: https://investors.medavail.com/. The webcast will be archived and available for replay after the event. About MedAvail MedAvail Holdings, Inc. (NASDAQ:MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharma